Dorsolateral nigral hyperintensity on 3.0T susceptibility‐weighted imaging in neurodegenerative Parkinsonism

Absence of a hyperintense, ovoid area within the dorsolateral border of the otherwise hypointense pars compacta of the substantia nigra (referred to as dorsolateral nigral hyperintensity) on iron‐sensitive high‐field magnetic resonance imaging sequences seems to be a typical finding for patients with Parkinson's disease (PD).

[1]  J. A. Burguera Hernández.  [Neuroimaging in movement disorders]. , 2005, Revista espanola de medicina nuclear.

[2]  D. Berg,et al.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson’s disease? Implications from MRI and TCS studies , 2012, Journal of Neural Transmission.

[3]  M. Tosetti,et al.  MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. , 2014, Radiology.

[4]  Thomas Gasser,et al.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.

[5]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[6]  R. Hilker,et al.  The value of putaminal diffusion imaging versus 18‐fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy , 2014, Movement disorders : official journal of the Movement Disorder Society.

[7]  Cyril Poupon,et al.  7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[8]  A. Quattrone,et al.  The midbrain to pons ratio: A simple and specific MRI sign of progressive supranuclear palsy , 2013, Neurology.

[9]  M. Hutchinson.  NEUROIMAGING OF MOVEMENT DISORDERS , 2008 .

[10]  D Perani,et al.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  B. Bloem,et al.  Update on diffusion MRI in Parkinson's disease and atypical parkinsonism , 2013, Journal of the Neurological Sciences.

[12]  A. Strafella,et al.  Imaging insights into basal ganglia function, Parkinson's disease, and dystonia , 2014, The Lancet.

[13]  R. Bowtell,et al.  Visualization of nigrosome 1 and its loss in PD , 2013, Neurology.

[14]  B. Bloem,et al.  Susceptibility-Weighted Imaging Improves the Diagnostic Accuracy of 3T Brain MRI in the Work-Up of Parkinsonism , 2015, American Journal of Neuroradiology.

[15]  Klaus Seppi,et al.  Proposed neuroimaging criteria for the diagnosis of multiple system atrophy , 2009, Movement disorders : official journal of the Movement Disorder Society.

[16]  A. Lees,et al.  What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)? , 2010, Movement disorders : official journal of the Movement Disorder Society.

[17]  A. Agresti,et al.  Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .

[18]  Klaus Seppi,et al.  Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7T MRI , 2014, Neurology.

[19]  W. Poewe,et al.  Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain‐to‐pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[20]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[21]  W. Poewe,et al.  Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[22]  Z. Cho,et al.  Seven‐tesla magnetic resonance images of the substantia nigra in Parkinson disease , 2012, Annals of neurology.

[23]  M. Schocke,et al.  Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease , 2010, Neurodegenerative Diseases.

[24]  Klaus Seppi,et al.  An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism , 2005, Current opinion in neurology.

[25]  M. Schocke,et al.  Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism , 2009, Movement disorders : official journal of the Movement Disorder Society.

[26]  W. Chan,et al.  Practical Aspects of Shortening Acquisition Time in Brain MR Susceptibility-Weighted Imaging , 2012, The neuroradiology journal.

[27]  Sonja W. Scholz,et al.  Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies , 2014, Parkinsonism & related disorders.

[28]  I Litvan,et al.  Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[29]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[30]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[31]  A. Stefani,et al.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.

[32]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[33]  N. Schuff.  Potential role of high‐field MRI for studies in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[34]  R A Crowther,et al.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[36]  Yasuo Terayama,et al.  Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. , 2014, Parkinsonism & related disorders.

[37]  Chandrasekharan Kesavadas,et al.  Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism , 2010, Neuroradiology.

[38]  D. Mikulis,et al.  The Value of GRE, ADC and Routine MRI in Distinguishing Parkinsonian Disorders , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[39]  S. Mirra,et al.  FILAMENTOUS AGGREGATES IN PICK'S DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND ALZHEIMER'S DISEASE SHARE ANTIGENIC DETERMINANTS WITH MICROTUBULE-ASSOCIATED PROTEIN, TAU , 1986, The Lancet.

[40]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[41]  R. Gasparotti,et al.  New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay , 2011, Insights into imaging.

[42]  Jörn Diedrichsen,et al.  Imaging the deep cerebellar nuclei: A probabilistic atlas and normalization procedure , 2011, NeuroImage.

[43]  Dorothee P. Auer,et al.  The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T , 2014, PloS one.

[44]  Klaus Seppi,et al.  Neuroimaging: Current role in detecting pre‐motor Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[45]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[46]  Z. Wu,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 , 2008, American Journal of Neuroradiology.

[47]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[48]  E. Haacke,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.

[49]  John Huston,et al.  Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging , 2011, Movement disorders : official journal of the Movement Disorder Society.

[50]  E M Haacke,et al.  Different Iron-Deposition Patterns of Multiple System Atrophy with Predominant Parkinsonism and Idiopathetic Parkinson Diseases Demonstrated by Phase-Corrected Susceptibility-Weighted Imaging , 2012, American Journal of Neuroradiology.

[51]  S. Kish,et al.  Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers , 1985, Annals of neurology.

[52]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.